ACMT Position Statement: Addressing Pediatric Cannabis Exposure

  • Maryann Mazer Amirshahi
  • Michael J. Moss
  • Silas W. Smith
  • Lewis S. Nelson
  • Andrew I. StolbachEmail author
Position Statement


In recent years, the use of medicinal cannabis has expanded, and cannabis has been decriminalized or legalized in many states. In addition to these changes in cannabis policy, there has been significant increase in the types, number, and potency of available products. Due to these changes in policy and availability, inadvertent cannabis exposures in children have been on the rise, leading to significant adverse events. ACMT believes stakeholders should implement measures to prevent pediatric cannabis poisonings.

For the purposes of this statement, we consider children to be individuals < 12 years of age. This position statement is not intended to address either the intentional use of cannabis by adolescents or prescription cannabidiol. We consider “exposure” to be contact between a person and a cannabis product. We characterize any adverse event due to exposure as “poisoning.”

Cannabis is the most commonly used illicit drug in the USA [1]. In recent years, many states have...


Sources of Funding


Compliance with Ethical Standards


While individual practitioners may differ, these are the positions of the American College of Medical Toxicology (ACMT) at the time written, after a review of the issue and pertinent literature.

Conflicts of Interest



  1. 1.
    Substance Abuse and Mental Health Administration. Results from the 2016 National Survey on Drug Use and Health: Detailed Tables. Rockville: Center for Behavioral Health Statistics and Quality; 2017. Accessed 14 Feb 2019.Google Scholar
  2. 2.
    Benjamin DM, Fossler MJ. Edible cannabis products: it is time for FDA oversight. J Clin Pharmacol. 2016;56(9):1054–7.CrossRefGoogle Scholar
  3. 3.
    Substance Abuse and Mental Health Administration. Highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. The DAWN Report. 2013. Accessed 14 Feb 2019.
  4. 4.
    Wang GS, Le Lait MC, Deakyne SJ, Bronstein AC, Bajaj L, Roosevelt G. Unintentional pediatric exposures to marijuana in Colorado, 2009- 2015. JAMA Pediatr. 2016;170(9):e160971.CrossRefGoogle Scholar
  5. 5.
    Wang GS, Roosevelt G, Le Lait MC, Martinez EM, Bucher-Bartelson B, Bronstein AC. Association of unintentional pediatric exposures with decriminalization of marijuana in the United States. Ann Emerg Med. 2014;63(6):684–9.CrossRefGoogle Scholar
  6. 6.
    Claudet I, Le Breton M, Brehin C, Franchitto N. A 10-year review of cannabis exposure in children under 3 years of age: do we need a more global approach? Eur J Pediatr. 2017;176(4):553–6.CrossRefGoogle Scholar
  7. 7.
    Pelissier F, Claudet I, Pelissier-Alicot AL, Franchitto N. Parental cannabis abuse and accidental intoxications in children: prevention by detecting neglectful situations and at-risk families. Pediatr Emerg Care. 2014;30(12):862–6.CrossRefGoogle Scholar
  8. 8.
    Wang GS, Roosevelt G, Heard K. Pediatric marijuana exposures in a medical marijuana state. JAMA Pediatr. 2013;67(7):630–3.CrossRefGoogle Scholar
  9. 9.
    Richards JR, Smith NE, Moulin AK. Unintentional cannabis ingestion in children: a systematic review. J Pediatr. 2017;190(Nov):142–52.CrossRefGoogle Scholar
  10. 10.
    Carstairs SD, Fujinaka MK, Keeney GE, Ly BT. Prolonged coma in a child due to hashish ingestions with quantitation of THC metabolites in urine. J Emerg Med. 2011;41(3):e69–71.CrossRefGoogle Scholar
  11. 11.
    Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32(4):1008–15.Google Scholar
  12. 12.
    Wong SS, Wilens TE. Medical cannabinoids in children and adolescents: a systematic review. Pediatrics. 2017;140(5):e20171818.CrossRefGoogle Scholar
  13. 13.
    Ryan SA, Ammerman SD, O’Connor ME, Committee On Substance Use And Prevention, Section On Breastfeeding. Marijuana use during pregnancy and breastfeeding: implications for neonatal and childhood outcomes. Pediatrics. 2018;142(3):e20181889.CrossRefGoogle Scholar

Copyright information

© American College of Medical Toxicology 2019

Authors and Affiliations

  • Maryann Mazer Amirshahi
    • 1
  • Michael J. Moss
    • 2
  • Silas W. Smith
    • 3
  • Lewis S. Nelson
    • 4
  • Andrew I. Stolbach
    • 5
    Email author
  1. 1.Department of Emergency Medicine, MedStar Washington Hospital CenterGeorgetown University School of MedicineWashingtonUSA
  2. 2.Utah Poison Control Center, College of PharmacyUniversity of UtahSalt Lake CityUSA
  3. 3.NYU School of MedicineNew YorkUSA
  4. 4.Rutgers New Jersey Medical SchoolNewarkUSA
  5. 5.Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations